what oncology drug developers should expect from the fda’s project optimus
Published 2 years ago • 4.5K plays • Length 54:26Download video MP4
Download video MP3
Similar videos
-
42:27
what you should know about fda project optimus for your oncology drug approval
-
31:44
echalk talk: how oncology drug developers can prepare for fda’s project optimus
-
59:00
what is fda project optimus and how will it impact oncology drug development?
-
12:07
the fda’s "project optimus" and oncology drugs
-
57:36
project optimus & pediatric drug development
-
1:05:36
project optimus – fda’s new dose optimization & selection paradigm in oncology drug development
-
1:00:38
project optimus- reimagining oncology drug development with dose optimization
-
11:35
2022 nhpdd day 1, session 2, part 3
-
55:19
how to define & measure clinical endpoints to optimize your oncology drug dosing
-
55:53
mechanistic model-informed discovery & development of bispecific antibodies for immuno-oncology
-
21:51
new horizons in pediatric drug development - day 1, session 2, part 1
-
1:47
the value of basecase
-
1:00:21
optimize drug development with public data and predictive models – model-based meta-analysis (mbma)
-
2:02
certara: pioneering innovation in drug development
-
43:49
how can model informed drug development impact your program?
-
35:08
fda modernization act - what does it mean for pharmaceutical scientists?
-
56:16
apocalyptic clinical pharmacology a comprehensive approach to drug development